Mylan N.V. (MYL) financial statements (2021 and earlier)

Company profile

Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE, AL10 9UL
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  3884031,1121,236
Cash and cash equivalents  3882929991,236
Short-term investments   111113 
Restricted cash and investments  178148 
Receivables  2,4173,1733,0152,689
Inventory, net of allowances, customer advances and progress billings  2,5802,5432,4561,951
Inventory  2,5802,5432,4561,951
Prepaid expense  131120138 
Other current assets  295369264 
Other undisclosed current assets  556528389597
Total current assets:  6,3687,2137,5236,473
Noncurrent Assets
Property, plant and equipment  2,1702,3392,3221,984
Intangible assets, net (including goodwill)  23,41225,45223,68012,602
Goodwill  9,74810,2069,2325,380
Intangible assets, net (excluding goodwill)  13,66515,24614,4487,222
Regulated entity, other noncurrent assets  747292(38)
Other noncurrent assets  212306569752
Other undisclosed noncurrent assets  499425541496
Total noncurrent assets:  26,36728,59327,20415,795
TOTAL ASSETS:  32,73535,80634,72622,268
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities  1,7391,5651,4461,202
Accounts payable  1,6171,4531,3481,110
Taxes payable  1221139892
Debt     1,078
Other liabilities  2,1482,9653,2591,842
Other undisclosed current liabilities  7021,855336 
Total current liabilities:  4,5886,3855,0414,122
Noncurrent Liabilities
Long-term debt and lease obligation  13,16112,86515,2036,296
Long-term debt, excluding current maturities  13,16112,86515,2036,296
Liabilities, other than long-term debt, including:  2401321132,084
Accounts payable and accrued liabilities    733 
Deferred tax liabilities, net1,7222,0122,006718
Liability for uncertainty in income taxes  162238239 
Liability, pension and other postretirement and postemployment benefits  398408397 
Other liabilities  1,0971,2361,3591,366
Other undisclosed liabilities, other than long-term debt  (3,139)(3,762)(4,621) 
Other undisclosed noncurrent liabilities  2,5793,1163,252 
Total noncurrent liabilities:  15,98016,11318,5688,380
Total liabilities:  20,56822,49923,60912,502
Stockholders' equity
Stockholders' equity attributable to parent  12,1677,90711,1169,764
Common stock  6666
Treasury stock, value  (1,000)(568)(68)(68)
Additional paid in capital  8,5918,5868,4997,129
Accumulated other comprehensive loss  (1,441)(118)(2,264)(1,764)
Retained earnings  6,011 4,9424,462
Stockholders' equity attributable to noncontrolling interest    11
Other undisclosed stockholders' equity   5,401  
Total stockholders' equity:  12,16713,30811,1189,766
TOTAL LIABILITIES AND EQUITY:  32,73535,80634,72622,268

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues  11,43411,90811,0779,429
Revenue, net11,90811,0779,429
Cost of revenue
(Cost of Goods and Services Sold)
  (7,432)(7,125)(6,380)(5,213)
Gross profit:  4,0024,7834,6974,216
Operating expenses  (3,096)(3,346)(3,995)(2,755)
Operating income:  9061,4377021,461
Nonoperating income (expense)  (65)1(230)(236)
Investment income, nonoperating    (105)(30)
Other nonoperating income (expense)  (65)1(125)(206)
Interest and debt expense  (542)(535)(491)(339)
Other undisclosed income from continuing operations before equity method investments, income taxes    14130
Income from continuing operations before equity method investments, income taxes:  298903122915
Loss from equity method investments    (113)(105)
Other undisclosed income from continuing operations before income taxes    113105
Income from continuing operations before income taxes:  298903122915
Income tax expense (benefit)  54(207)358(68)
Net income:  353696480848
Net loss attributable to noncontrolling interest     (0)
Net income available to common stockholders, diluted:  353696480848

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:  353696480848
Other comprehensive income (loss)  (1,073)1,903(499)(777)
Comprehensive income (loss):  (720)2,599(19)70
Comprehensive loss, net of tax, attributable to noncontrolling interest     (0)
Comprehensive income (loss), net of tax, attributable to parent:  (720)2,599(19)70

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: